GARDASIL (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the GARDASIL drug offered from Merck Sharp & Dohme Corp.. This Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant |
| SUBSTANCE NAME: | HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 C |
| TYPE: | VACCINE |
| PHARMA CLASS: | Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2006-06-08 |
| END MARKETING DATE: | 0000-00-00 |
GARDASIL VACCINE Details:
| Item Description | GARDASIL from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 40; 40; 20(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL) |
| START MARKETING DATE: | 2006-06-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-4045_eb224f0a-88db-4a63-9020-0bb55682833e |
| PRODUCT NDC: | 0006-4045 |
| APPLICATION NUMBER: | BLA125126 |
Other HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 C Pharmaceutical Manufacturers / Labelers:
